# Bosentan in Children With Pulmonary Arterial Hypertension

> **NCT00319267** · PHASE3 · COMPLETED · sponsor: **Actelion** · enrollment: 36 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Bosentan

## Key facts

- **NCT ID:** NCT00319267
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-12
- **Final completion:** 2007-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319267, "Bosentan in Children With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00319267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*